CARLOS MANUEL
PANIZO SANTOS
Universidad de Sevilla
Sevilla, EspañaPublications in collaboration with researchers from Universidad de Sevilla (1)
2022
-
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
Leukemia and Lymphoma, Vol. 63, Núm. 4, pp. 821-833